OCLN and neoplasm: Particularly noteworthy is the unique immunomodulatory properties of NMS: on one hand, it inhibits tumor malignant progression by downregulating the proliferation marker Ki-67; on the other hand, it improves intestinal barrier function by enhancing the expression of tight junction protein Occludin and reducing LPS levels.